MICHAEL H. MULROY - Corporate Board Profile

Lineage Cell Therapeutics, Inc.

Filing Date	Source Excerpt
2014-10-14	Michael H. Mulroy, 48, joined our Board of Directors during October 2014... The following table shows the annual cash fees paid to our directors other than the Chairman... Director other than Chairman $30,000.
2015-06-11	Michael H. Mulroy, 49, joined our Board of Directors during October 2014. Mr. Mulroy is a business consultant and serves as the President of Mulroy Advisors, LLC. The members of the Nominating and Corporate Governance Committee are Neal C. Bradsher (Chairman), Stephen C. Farrell, and Michael H. Mulroy. Michael H. Mulroy received $13,375 in fees and $25,048 in option awards for a total of $38,423.
2016-04-29	Michael H. Mulroy, 50, joined our Board of Directors during October 2014. Mr. Mulroy is a business consultant and serves as the President of Mulroy Advisors, LLC... The members of the Nominating and Corporate Governance Committee are Neal C. Bradsher (Chairman), Stephen C. Farrell, and Michael H. Mulroy... DIRECTOR COMPENSATION table shows Michael H. Mulroy total compensation of $97,677.
2017-05-01	Michael H. Mulroy, 51, joined our Board of Directors during October 2014... The members of the Audit Committee are Deborah Andrews (Chairwoman), Stephen C. Farrell, Michael H. Mulroy, and David Schlachet... The members of the Compensation Committee are Deborah Andrews, Stephen C. Farrell (Chairman), and David Schlachet... The members of the Nominating and Corporate Governance Committee are Neal C. Bradsher (Chairman), Stephen C. Farrell, Michael H. Mulroy, and Angus C. Russell... DIRECTOR COMPENSATION table shows Michael H. Mulroy total compensation of $176,674.
2018-03-29	Michael H. Mulroy, 52, joined our Board of Directors during October 2014. ... Mr. Mulroy served as Chairman of the Technology Value Committee until it dissolved on July 9, 2017. ... DIRECTOR COMPENSATION table shows Michael H. Mulroy total compensation of $283,396.
2019-06-14	Michael H. Mulroy. Mr. Mulroy served as the Chief Executive Officer and a member of the board of directors of Asterias Biotherapeutics, Inc. ... Mr. Mulroy brings to our Board his experience as the Chief Executive Officer of a publicly traded biotechnology company and member of a senior management team of a larger biopharmaceutical company that experienced a period of rapid growth. ... Committees: Compensation (Chair) ... 2018 Director Compensation ... Michael H. Mulroy $40,000 Fees Earned or Paid in Cash, $33,045 Option Award, Total $73,045.
2020-08-07	Michael H. Mulroy served as the Chief Executive Officer and a member of the board of directors of Asterias Biotherapeutics, Inc. ... The members of our Compensation Committee are Michael H. Mulroy (Chair), Deborah Andrews, and Stephen C. Farrell. ... The members of our Nominating and Corporate Governance Committee are Don M. Bailey (Chair), Deborah Andrews, Neal C. Bradsher, and Michael H. Mulroy. ... The members of our Financial Strategy Committee are Alfred D. Kingsley (Chair), Don M. Bailey, Neal C. Bradsher, and Michael H. Mulroy. ... Michael H. Mulroy $49,973 Fees Earned or Paid in Cash, $23,261 Option Award, $73,234 Total.
2021-08-03	Michael H. Mulroy. Mr. Mulroy served as the Chief Executive Officer and a member of the board of directors of Asterias Biotherapeutics, Inc. (AST) from June 2017 until our acquisition of Asterias in March 2019. ... Mr. Mulroy brings to our Board his experience as the Chief Executive Officer of a publicly traded biotechnology company and member of a senior management team of a larger biopharmaceutical company that experienced a period of rapid growth. Mr. Mulroy also brings to our Board his experience in corporate finance, investor relations and information systems and security.
2022-04-29	Michael H. Mulroy. Mr. Mulroy served as the Chief Executive Officer and a member of the board of directors of Asterias Biotherapeutics, Inc. (AST) from June 2017 until our acquisition of Asterias in March 2019. ... Mr. Mulroy brings to our Board his experience as the Chief Executive Officer of a publicly traded biotechnology company and member of a senior management team of a larger biopharmaceutical company that experienced a period of rapid growth. ... The following table summarizes certain information concerning the compensation during our fiscal year ended December 31, 2021 to each person who served as a non-employee director during the year and who was not our employee on the date the compensation was earned. ... Michael H. Mulroy $71,000 Fees Earned or Paid in Cash, $89,555 Option Award, $160,555 Total.
2023-07-27	Michael H. Mulroy. Mr. Mulroy served as the Chief Executive Officer and a member of the board of directors of Asterias Biotherapeutics, Inc. (AST) from June 2017 until our acquisition of Asterias in March 2019. ... Mr. Mulroy brings to our Board his experience as the Chief Executive Officer of a publicly traded biotechnology company and member of a senior management team of a larger biopharmaceutical company that experienced a period of rapid growth. Mr. Mulroy also brings to our Board his experience in corporate finance and investor relations. ... The table below shows the average annual cash fees for 2022 and the current cash fees, which became effective as of April 1, 2023. ... The following table summarizes certain information concerning the compensation during our fiscal year ended December 31, 2022 to each person who served as a non-employee director during the year and who was not our employee on the date the compensation was earned. ... Michael H. Mulroy $73,000 Fees Earned or Paid in Cash, $78,500 Option Award, $151,500 Total.
2024-04-29	Michael H. Mulroy. Mr. Mulroy was appointed Chairman of the Board in April 2024. ... Our Audit Committee also has oversight of risks related to information security ... Our Board has determined that Ms. Andrews, Dr. Amin, Mr. Bailey, Mr. Bradsher, Dr. Jayasuriya, Mr. Mulroy, and Mr. Russell qualify as “independent” directors ... The table below sets forth the composition of the committees of our Board as of April 25, 2024: ... Michael H. Mulroy: Audit Committee Member, Compensation Committee Chair, Nominating & Corporate Governance Committee Member, Financial Strategy Committee Member ... 2023 Non-Employee Director Compensation Table: Michael H. Mulroy total $151,125.
2024-12-09	The Audit Committee of our Board, which is comprised solely of independent directors Ms. Andrews, Messrs. Bailey and Mulroy, and Angus C. Russell.